Canadian Pharmacy Spam Sites

Buying Prescription Drugs Online Scam Alert 1
May Be Dangerous
Says Drug Enforcement Administration


DEA Logo - Buying Percription Drugs

National Association of Boards of Pharmacy (NABP)

Warning

“The Canadian Pharmacy, Canadian/European Pharmacy”, “Canadian Healthcare” and “US Drugstore” are brands of one of the most disgusting illegal online pharmacy group well organized CRIMINAL OPERATION of all times. “GREED” is the driving force behind this operation. Don’t let them fool you. They will never send you any genuine drugs. If they ever send anything at all, it may consist of literally anything from sugar to wall plaster, and they certainly don’t care that you will endanger your health by taking those dangerous counterfeit drugs.

Behind The Online Pharmacy

Today a shadowy, transnational network of illicit drug manufacturers, traders, doctors, Web site operators, spammers and criminals makes up the online pharmacy world.

Buying Medication Online Can Be Safe

There are many options out there when it comes to buying medication online. We have looked at websites after websites. Some sites feature offshore pharmacies that do not require a prior prescription. Others feature licensed pharmacies that do require a prescription from your doctor.
Before making a purchase that can effect your health, we strongly recommend that you consult your physician & DO NOT self-medicate. Ordering medication online can be a safe, money-saving experience. When done through licensed online pharmacies that require a prescription, you can be assured that the medication you get is exactly what you need to treat your ailments.


More of These Canadian Spam Scamming Domains

  1. retoleh.cn
  2. pujokek.cn
  3. fibijih.cn
  4. tetelah.cn
  5. bimilic.cn
  6. pamehoy.cn
  7. rorugok.cn
  8. lidemob.cn
  9. qobemiq.cn
  10. vineyuh.cn
  11. livumeg.cn
  12. dozalid.cn
  13. xoloxih.cn
  14. navijid.cn
  15. gejawir.cn
  16. honijaj.cn
  17. cuduvos.cn


Solvent Group Inc – solvent-groupinc.org

The Purpose of This Post Is To ALERT You That The Job You Are About To APPLY For or May Have Applied For or is CONSIDERING APPLYING For Is Scam Alert 1Fraudulent. A LEGITIMATE COMPANY IDENTITY OR AN INDIVIDUAL IDENTITY HAS BEEN STOLEN OR A BOGUS ONE CREATED

These job postings are an attempt to lure you into cashing counterfeit checks and have you wire funds via Western Union or MoneyGram -Essentially You Become A Money or RePackage Mule

Money Mule Explained

Read All About This at Symantec Corp.

Washingtonpost.com by Brian Kerbs


Financial Manager                                                                            

 

Location: USA, statewide
Availability: currently available
Employment type: Part-time employment
Number of employees required: 3

CANDIDATE REQUIREMENTS.

* not less than 18 years old
* internet access to reply emails promptly
* availability by phone (1-2 hours a day)
* a bank account to process payments
* good credit history with your bank (new bank account is an option)
* no criminal offense or convictions
* experience in the field of finance is preferred

DUTIES

We are searching for people to process payments coming from our clients. ALT Group Inc will provide an agent with detailed instructions as regards payment processing operations including sender full name and amount total for each separate case.

When funds enter employee’s bank account, Financial Agent’s duty is to withdraw cash and transfer the funds via International Wire Transfer or Western Union/Money Gram money transfer systems. The main advantage of our services is the shortest possible time within which the seller can receive money for the services/goods sold. If this operation is delayed, our clients are entitled to cancel their contract with us and we suffer financial loss. Therefore, successful applicant must be very responsible and careful!

TRIAL PERIOD POLICY

Successful applicants are offered the position on a probationary period basis (1 month). This is the period when a new employee will be trained and receive online support while working and being paid. A personal supervisor can recommend termination during/after the trial period depending on agent’s activity. New employee should be responsible and strictly follow supervisor’s recommendations to pass the Probationary Period successfully and be employed by us on a regular basis.

SALARY

During the probationary period we offer USD 2,300 monthly salary plus 8% commission for each payment processing operation. For example, an average $5,000 payment will entail $400 commission (but WU/MG fee is paid from this money, please see for more details below). Furthermore, we offer $50 bonus for each transaction completed by 11 a.m. (local time). With the current number of clients, on average, your overall income will amount to up to USD 4,000 per month. A successful agent may ask for additional tasks and earn more. After the probationary period base salary will be as high as USD 3,000 per month plus 8% commission. Base salary ($2,300) will be transferred at the end of each month to employee’s bank account. Commission (8%) is to be deducted from the processed money.

IMPORTANT DETAILS

* Financial Agent is supposed to process received assets during one business day, i.e. from the moment of money entering his bank account to the moment of re-send to our client in accordance with contract terms. If money enters employee’s account on a day-off or holiday, all payment processing procedures have to be completed during the next working day.
* Financial Agent receives invoices for each transaction every 14 days. This document is a confirmation of transaction validity, and in case of any (if any at all) unforeseen circumstances it will evidence your personal non-participation. All invoices will contain detailed information on money sender and will be both sealed and certified with President’s signature.
*After the Probationary Period completion, invoices will be sent every business day.
* Since business transfers can be processed with delays, Financial Manager should specify each transfer as a private remittance. This provision is also applicable in case of a third party interest in the transfer.
* Our clients appreciate our operational efficiency and are ready to pay extra fee for shorter transaction terms. If we manage to deliver goods to buyer within 10 days, the deal is considered to be fulfilled at the earliest possible date.
* All the fees (WU/MG) are paid from employee’s commission. HOWEVER, our company undertakes to reimburse part of expenses which are incurred in connection with money transfer (WIRE or by Western Union/Money gram system) should money transfer charges exceed 3%. All in all, your net profit will amount to 5-8% of the total amount of each payment processing operation.
* We don’t ask for any investment to start cooperating with our company.
* The company offers incentive bonus program based on work results with regard to several factors, i.e. total sum of money transferred, payment processing time, etc.

OUR BENEFITS

Probationary period imposes restrictions on the employment benefits of our corporation. Financial Manager will be able to receive ALT Group Inc employment benefits only after probationary period completion. Employment benefits will include:

* stock options
* child-care subsidies
* flex-time
* business casual attire
* free training and professional development programs

*Detailed information concerning the employment benefits will be provided after probationary period successful completion.

Main Address:
Office Suites
1221 Avenue of the Americas
Floor 45
New York, NY USA
USA

Tel: 1-646-419-4256
Fax: 1-646-478-9235

cronos-group

  • alt-groupinc.com
  • alt-groupco.net
  • alt-groupco.cn
  • altgroupco.cn
  • reddbutton.cn
  • DIAMOND-DREAM.CC
  • DUMMYKEATH.CC
  • WINDCONTROL.CC
  • iris-groupinc.com
  • land-groupsvc.com
  • mellis-groupinc.com
  • igt-groupinc.com
  • integrity-groupsvc.com
  • annuity-groupllc.com
  • affina-groupnet.com
  • saturn-groupsvc.com
  • cosco-groupmain.com
  • itsgroupsvc.com
  • intrade-groupinc.com
  • imex-groupinc.org
  • master-groupinc.org
  • solvent-groupinc.org
  • walt-group.org
  • star-groupinc.net
  • extreme-groupinc.com
  • united-groupnet.com
  • mena-groupsvc.com
  • massive-groupsvc.com
  • trans-groupmain.com
  • medium-groupsvc.com
  • holding-groupinc.com
  • utcgroupinc.com

Domains on Nameserver ns1.full-controll.cc
Domain

  • igt-group.org
  • landgroupinc.net
  • mellisgroupmain.net
  • phoenix-groupco.net
  • indexgroupinc.net
  • alt-groupco.net
  • cronos-group.net
  • rengo-groupli.com
  • broadex-groupsvc.com
  • solvent-group.com
  • walt-groupsvc.com
  • fancy-groupmain.com

Domains on Nameserver ns2.full-controll.cc
Entries 1 – 12 of 12
Domain

  • imex-groupinc.org
  • irisgroupinc.org
  • master-groupinc.org
  • solvent-groupinc.org
  • walt-group.org
  • thejoboffer.net
  • braingroupinc.net
  • melson-groupmain.com
  • ibc-groupinc.com
  • credit-groupinc.com
  • fusion-groupsvc.com
  • mac-groupinc.com


Domains on Nameserver ns3.full-controll.cc
Entries 1 – 10 of 10
Domain

  • star-groupinc.net
  • extreme-groupinc.com
  • united-groupnet.com
  • mena-groupsvc.com
  • massive-groupsvc.com
  • rengo-groupmain.com
  • star-groupsvc.com
  • phoenix-groupmain.com
  • brain-groupsvc.com
  • cronos-groupinc.com
  • alt-groupinc.com
  • armor-groupco.cn
  • assurity-groupco.cn
  • assurity-groupinc.cn
  • bubblepreorder.net
  • certgroupinc.cn
  • cosco-groupli.cn
  • cosco-groupli.com
  • emerge-groupli.cn
  • emerge-groupsvc.cn
  • entrust-groupsvc.cn
  • focus-groupsvc.cn
  • frewgroupmain.cc
  • hugegroupfly.cc
  • massive-groupsvc.cn
  • opm-groupli.cn
  • scope-group.cn
  • scope-groupmain.cn
  • solar-groupco.com
  • total-groupli.cn
  • totallysmiled.cn
  • wfs-groupsvc.cn
  • bcg-groupmain.cn
  • bubble-preorder.info
  • cosco-groupli.cn
  • diamond-dream.cc
  • gio-groupmain.cn
  • integrity-groupsvc.com
  • lime-groupnet.cc
  • mena-groupsvc.com
  • opm-groupli.cn
  • prime-groupinc.cc
  • prospera-groupli.cn
  • redeye-groupinc.cc
  • saturn-groupco.cn
  • saturn-groupsvc.com
  • scope-group.cn
  • scope-groupmain.cn
  • total-groupli.cn
  • totallysmiled.cn
  • trans-groupmain.com
  • united-groupnet.com

Domains on Nameserver ns3.reddbutton.cn

Entries 1 – 6 of 6

Domains on Nameserver ns1.windcontrol.cc

Entries 1 – 8 of 8
Domain
irisgroupinc.org
thejoboffer.net
braingroupinc.net
invalda-groupmain.com
imex-groupinc.com
index-groupinc.com
alt-groupinc.com
master-groupinc.com

Address lookup

canonical name solvent-groupinc.org.
aliases
addresses 222.35.137.235

Domain Whois record

Queried whois.publicinterestregistry.net with “solvent-groupinc.org”…
Domain ID:D157082464-LROR
Domain Name:SOLVENT-GROUPINC.ORG
Created On:11-Sep-2009 12:53:40 UTC
Last Updated On:11-Nov-2009 03:56:30 UTC
Expiration Date:11-Sep-2010 12:53:40 UTC
Sponsoring Registrar:Xin Net Technology Corporation (R118-LROR)
Status:OK

Registrant ID:n2gp92lgvhq063
Registrant Name:Jamel
Registrant Organization:Straker
Registrant Street1:25309 C Street
Registrant Street2:
Registrant Street3:
Registrant City:Beale AFB
Registrant State/Province:beijing
Registrant Postal Code:95903
Registrant Country:CN
Registrant Phone:+86.2282572719
Registrant Phone Ext.:
Registrant FAX:+86.2282572719
Registrant FAX Ext.:
Registrant Email:MarcusStraker909@gmail.com

Admin ID:n2gp92lgvhq063a
Admin Name:Jamel
Admin Organization:Jamel
Admin Street1:25309 C Street
Admin Street2:
Admin Street3:
Admin City:Beale AFB
Admin State/Province:beijing
Admin Postal Code:95903
Admin Country:CN
Admin Phone:+86.2282572719
Admin Phone Ext.:
Admin FAX:+86.2282572719
Admin FAX Ext.:
Admin Email:MarcusStraker909@gmail.com

Tech ID:n2gp92lgvhq063a
Tech Name:Jamel
Tech Organization:Jamel
Tech Street1:25309 C Street
Tech Street2:
Tech Street3:
Tech City:Beale AFB
Tech State/Province:beijing
Tech Postal Code:95903
Tech Country:CN
Tech Phone:+86.2282572719
Tech Phone Ext.:
Tech FAX:+86.2282572719
Tech Email:MarcusStraker909@gmail.com

Name Server:NS1.DIAMOND-DREAM.CC
Name Server:NS2.FULL-CONTROLL.CC

DNSSEC:Unsigned

Network Whois record

Queried whois.apnic.net with “222.35.137.235”…
inetnum: 222.32.0.0 – 222.63.255.255
netname: CRTC
descr: CHINA RAILWAY TELECOMMUNICATIONS CENTER
descr: 22F Yuetan Mansion,Xicheng District,Beijing,P.R.China
country: CN
admin-c: LQ112-AP
tech-c: LM273-AP
status: ALLOCATED PORTABLE
mnt-by: MAINT-CNNIC-AP
changed: hm-changed@apnic.net 20030902
source: APNIC

route: 222.32.0.0/11
descr: China TieTong Telecommunications Corporation
country: CN
origin: AS9394
mnt-by: MAINT-CNNIC-AP
changed: ipas@cnnic.net.cn 20090908
source: APNIC

person: LV QIANG
nic-hdl: LQ112-AP
e-mail: crnet_mgr@chinatietong.com
address: 22F Yuetan Mansion,Xicheng District,Beijing,P.R.China
phone: +86-10-51892111
fax-no: +86-10-51847845
country: CN
changed: ipas@cnnic.net.cn 20060911
mnt-by: MAINT-CNNIC-AP
source: APNIC

person: liu min
nic-hdl: LM273-AP
e-mail: abuse@chinatietong.com
address: 22F Yuetan Mansion,Xicheng District,Beijing,P.R.China
phone: +86-10-51848796
fax-no: +86-10-51842426
country: CN
changed: ipas@cnnic.net.cn 20041208
mnt-by: MAINT-CNNIC-AP
source: APNIC

inetnum: 222.32.0.0 – 222.63.255.255
netname: CRTC
descr: CHINA RAILWAY TELECOMMUNICATIONS CENTER
descr: 22F Yuetan Mansion,Xicheng District,Beijing
country: CN
admin-c: LQ112-CN
tech-c: LM273-CN
status: ALLOCATED PORTABLE
changed: hm-changed@apnic.net 20030902
mnt-by: MAINT-CNNIC-AP
source: CNNIC

person: LV QIANG
nic-hdl: LQ112-CN
e-mail: crnet_mgr@chinatietong.com
address: 22F Yuetan Mansion,Xicheng District,Beijing
phone: +86-10-51892111
fax-no: +86-10-51847845
country: CN
changed: ipas@cnnic.cn 20060419
mnt-by: MAINT-CNNIC-AP
source: CNNIC

person: liu min
nic-hdl: LM273-CN
e-mail: crnet_tec@chinatietong.com
address: 22F Yuetan Mansion,Xicheng District,Beijing,P.R.China
phone: +86-10-51848796
fax-no: +86-10-51842426
country: CN
changed: ipas@cnnic.net.cn 20041208
mnt-by: MAINT-CNNIC-AP
source: CNNIC

DNS records

DNS query for 235.137.35.222.in-addr.arpa returned an error from the server: NameError

name class type data time to live
solvent-groupinc.org IN SOA
server: ns1.diamond-dream.cc
email: root.ns1.diamond-dream.cc
serial: 911271232
refresh: 300
retry: 120
expire: 86400
minimum ttl: 60
120s (00:02:00)
solvent-groupinc.org IN A 222.35.137.235 120s (00:02:00)
solvent-groupinc.org IN NS ns2.full-controll.cc 120s (00:02:00)
solvent-groupinc.org IN NS ns1.diamond-dream.cc 120s (00:02:00)
solvent-groupinc.org IN MX
preference: 10
exchange: mx.solvent-groupinc.org
120s (00:02:00)

— end —

WWW.24-7rx.com AND www.bestdealrx.com

From: FDA Center for Drug Evaluation and Research
FDAlnternetPharmacyTaskForce-CDER@fda.hhs.gov

Date: November 16, 2009
TO: Ric Deleon                                                                          
21 Villamor Street
Manila, Manila 2700
bastprices2000@yahoo.com
UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES
FOOD AND DRUG ADMINISTRATION
ROCKVILLE, MD 20903

TO: Ric Deleon
FROM: Food and Drug Administration Internet Pharmacy Task Force
RE: Internet Marketing of Unapproved and Misbranded Drugs
DATE: November 16, 2009

Warning Letter

The United States Food and Drug Administration (FDA) has reviewed your websites at

247meds.com
24-7pills.com
24-7rx.com
bestdealrx.com
and has determined that you are offering products for sale in violation of the Federal Food, Drug, and Cosmetic Act (the Act).
These products include, but are not limited to, “Acomplia (Generic),” “Acomplia (Brand),” “Rimonabant,” “Herbal Xanax,” “Herbal Ambien,” “Herbal Viagra,” “Viagra (Brand),” “Xanax (Brand),” and “Valium (Brand).”

We request that you immediately cease marketing violative
products.

These products are drugs under section 201 (g) of the Act, 21 U.S.C. § 321 (g), because they are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease and/or because they are intended to affect the structure or function of the body. Your marketing and distribution of these drugs violate various provisions of the Act, as described below:

Unapproved New Drugs

Your firm offers many unapproved new drugs including, but not limited to Acomplia (Generic),”
“Acomplia (Brand),” “Rimonabant,” “Herbal Xanax,· “Herbal Ambien,· and “Herbal Viagra.” FDA is taking this action against your firm because of the inherent risk in buying unapproved prescription drugs. Unapproved drugs from unregulated sources do not have the same
assurance of safety and effectiveness as drugs subject to FDA oversight and have been found to be contaminated, counterfeit, contain varying amounts of active ingredients, or contain different ingredients altogether. For drugs that are regulated by FDA, FDA protections include rigorous scientific standards for prescription drug approval and label review for accuracy and completeness, manufacturing procedures and testing performed under closely controlled conditions at FDA-registered and inspected facilities. In addition, pharmacies and wholesalers who sell or distribute prescription drugs in the U.S. are licensed by the states. Unapproved new drugs delivered to the American public from unregulated sources may not be safe and effective.

Rimonabant (also marketed under the name Acomplia) was specifically rejected for FDA approval because it did not meet the statutory requirements for safety and effectiveness. In June 2007, the FDA Endocrinologic and Metabolic Drugs Advisory Committee unanimously voted not to recommend approval of the drug because of increased risk of neurological and psychiatric side effects including seizures, depression, anxiety, insomnia, aggressiveness, and suicidal thoughts
among patients. Accordingly, the “Acomplia (Generic),” “Acomplia (Brand),” and “Rimonabant,” dispensed through your websites are “new drugs,” as defined by section 201 (p) of the Act, 21 .S.C. § 321(p), because it is not generally recognized as safe and effective for its labeled uses.

You also offer “Herbal Xanax,” “Herbal Ambien,” and “Herbal Viagra” on your websites. Xanax, Ambien, and Viagra are approved drugs well-known for their intended use(s) to treat disease.
Therefore, including these drug names causes “Herbal Xanax,” “Herbal Ambien,” and “Herbal Viagra” to be subject to regulation as drugs under Section 201 (g) of the Act because they are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease.
Moreover, these products are new drugs, as defined by section 201 (p) of the Act, 21 U.S.C. § 321 (p).

Under sections 301 (d) and 505(a) of the Act, 21 U.S.C. §§ 331 (d) and 355(a), a new drug may not be introduced or delivered for introduction into interstate commerce unless an FDA-approved
application is in effect for it. Your sale of several products, including but not limited to “Acomplia (Generic),” “Acomplia (Brand),” “Rimonabant,” “Herbal Xanax,” “Herbal Ambien,” and “Herbal Viagra,” without approved applications violates these provisions of the Act.

Misbranded Drugs

Your websites offer several products, including but not limited to “Viagra (Brand),” “Xanax (Brand),” and “Valium (Brand),” for sale without requiring that the products be dispensed under a prescription from a duly licensed practitioner. Some of the products available on your website are also controlled substances; the sale of these products is particularly concerning because of the potential for abuse and dependency. Therefore, the drugs are misbranded under section
503(b)(1) of the Act, 21 U.S.C. § 353(b)(1), and are marketed in violation of sections 301 (a), 301 (b), and 301 (k) of such Act, 21 U.S.C. §§ 331 (a), 331 (b), and 331 (k).

Further, your websites offer products for sale and state that they are FDA-approved. As noted above, your products are not FDA-approved and are offered for sale in violation of the Act.
Therefore, these products are misbranded under section 502(a) of the Act, 21 U.S.C. § 352(a), because the labeling of the drugs is false and misleading.

In addition, you offer “Herbal Xanax,” “Herbal Ambien,” and “Herbal Viagra” for sale. These drugs  are misbranded under section 502(a) of the Act, 21 U.S.C. § 352(a), because the labeling of the drugs are false and misleading. The labeling are false and misleading because they erroneously suggest that the products contain Xanax, Ambien, and Viagra, which are the proprietary names for FDA-approved products containing the active pharmaceutical ingredients alprazolam,
zolpidem, and sildenafil citrate. Regardless of whether your products contain Xanax, Ambien, or Viagra, the products you are offering for sale are not manufactured by the sponsors of the approved applications for Xanax, Ambien, or Viagra, and it is false and misleading to suggest that
your products are manufactured by that sponsor.

The introduction or delivery for introduction into interstate commerce of these misbranded products violates section 301 (a) of the Act, 21 U.S.C. § 331 (a).

This letter is not intended to identify all of the ways in which your activities might be in violation of United States law. It is your responsibility to ensure that all products marketed by your firm are in compliance with the Act and its implementing regulations. You should take prompt action to correct the violations noted above. Failure to correct these violations promptly may result in regulatory action, including but not limited to, seizure and/or injunction without further notice.

Please notify this office in writing within 15 working days of receipt of this letter of any steps you have taken or will take to correct the noted violations and to prevent their recurrence. If the corrective action(s) cannot be completed within 15 working days, state the reason for the delay and the time within which the correction(s) will be completed. Your response should be sent to FDAlnternetPharmacyTaskForce-CDER@fda.hhs.gov. Please direct any inquiries concerning this letter to FDA’s Internet Pharmacy Task Force at FDAlnternetPharmacyTaskForceCDER@fda.hhs.gov or (301) 796-3110.
Sincerely,

/S/

Deborah M. Autor, Esq.
Director
Office of Compliance
Center for Drug Evaluation and Research

Pro West Marketing Ltd – buycanadianpharmacy.net

From: FDA Center for Drug Evaluation and Research

FDAlnternetPharmacyTaskForce-CDER@fda.hhs.gov
Date: November 16, 2009

TO:       Pro West Marketing Ltd, Rue de                                       
L’arc 45, Road Town, Tortola,
BVI VG1110

UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES

FOOD AND DRUG ADMINISTRATION
ROCKVILLE, MD 20903

TO:    Pro West Marketing Ltd
FROM: Food and Drug Administration Internet Pharmacy Task Force
RE:     Internet Marketing of Unapproved and Misbranded Drugs
DATE:  November 16, 2009

Warning Letter

The United States Food and Drug Administration (FDA) has reviewed your websites at

  • doctorphentermine.com
  • trusted-tabs.us
  • online-pharmacy-no-prescription.com
  • 365pharm.com
  • approved-pharm.com
  • value-drugstore.com
  • cheapphentermine.com
  • rx-giant.com
  • 4cheaprx.com
  • preferredpharma.com
  • prescriptionsintl.com
  • aprixe.com
  • buycanadianpharmacy.net
  • terameds.org
  • dragon-rx.com
  • first-refill-c1ub.com
  • bestrxpharm.net
  • pharma-direct.com
  • buy-canadian-pharm.com
  • easy-pharm.com
  • licensed-medical.com
  • my-refilldrugstore. com
  • refill-rx-now.com
  • rxcalm.com
  • top-hotpills.com
  • top-uspharm.com
  • my-pill.com
  • smsrx.net
  • total-pharma.com
  • pharma-discounts.com
  • rxontv.com

and has determined that you are offering products for sale in violation of the Federal Food, Drug, and Cosmetic Act (the Act). These products include, but are not limited to, “Acomplia (Generic),” “Acomplia (Brand),” “Rimonabant,” “Viagra (Brand),” “Cialis (Brand),” “Prozac (Generic): and “Levitra (Brand).” We request that you immediately cease marketing violative products.

These products are drugs under section 201(g) of the Act, 21 U.S.C. § 321(g), because they are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease and/or because they are intended to affect the structure or function of the body. Your marketing and distribution of these drugs violate various provisions of the Act, as described below:

Unaporoved New Drugs

Your firm offers many unapproved new drugs including, but not limited to “Acomplia (Generic),” “Acomplia (Brand),” and “Rimonabant.” FDA is taking this action against your firm because of the inherent risk in buying unapproved prescription drugs. Unapproved drugs from unregulated sources do not have the same assurance of safety and effectiveness as drugs subject to FDA oversight and have been found to be contaminated, counterfeit, contain varying amounts of active ingredients, or contain different ingredients altogether. For drugs that are regulated by FDA, FDA protections include rigorous scientific standards for prescription drug approval and label review for accuracy and completeness, manufacturing procedures and testing performed under closely controlled conditions at FDA-registered and inspected facilities. In addition, pharmacies and wholesalers who sell or distribute prescription drugs in the U.S. are licensed by the states. Unapproved new drugs delivered to the American public from unregulated sources may not be safe and effective.

Rimonabant (also marketed under the name Acomplia) was specifically rejected for FDA approval because it did not meet the statutory requirements for safety and effectiveness. In June 2007, the FDA Endocrinologic and Metabolic Drugs Advisory Committee unanimously voted not to recommend approval of the drug because of increased risk of neurological and psychiatric side effects including seizures, depression, anxiety, insomnia, aggressiveness, and suicidal thoughts among patients. Accordingly, “Acomplia (Generic),” “Acomplia (Brand),” and “Rimonabant” dispensed through your websites are new drugs, as defined by section 201(p) of the Act, 21 U.S.C. § 321 (p).

Under sections 301(d) and 505(a) of the Act, 21 U.S.C. §§ 331(d) and 355(a), a new drug may not be introduced or delivered for introduction into interstate commerce unless an FDA-approved application is in effect for it. Your sale of several products, including “Acomplia (Generic),” “Acomplia (Brand),” and “Rimonabant” without approved applications violates these provisions of the Act.

Misbranded Drugs

Many of your websites sell products, including but not limited to “Viagra (Brand),” “Cialis (Brand),” “Prozac (Generic),” and “Levitra (Brand)” without requiring that the products be dispensed under a prescription from a duly licensed practitioner. Therefore, the drugs are misbranded under section 503(b)(1) of the Act, 21 U.S.C. § 353(b)(1), and are marketed in violation of sections 301(a), 301(b), and 301(k) of such Act, 21 U.S.C. §§ 331(a), 331(b), and 331(k).

Further, most of your websites state that your products are FDA-approved. As noted above, your products are not FDA-approved and are offered for sale in violation of the Act. Therefore, these products are misbranded under section 502(a) of the Act, 21 U.S.C. § 352(a), because the labeling of the drugs is false and misleading.

The introduction or delivery for introduction into interstate commerce of these misbranded products violates section 301 (a) of the Act, 21 U.S.C. § 331(a).

This letter is not intended to identify all of the ways in which your activities might be in violation of United States law. It is your responsibility to ensure that all products marketed by your firm are in compliance with the Act and its implementing regulations. You should take prompt action to correct the violations noted above. Failure to correct these violations promptly may result in regulatory action, including but not limited to, seizure and/or injunction without further notice.

Please notify this office in writing within 15 working days of receipt of this letter of any steps you have taken or will take to correct the noted violations and to prevent their recurrence. If the corrective action(s) cannot be completed within 15 working days, state the reason for the delay and the time within which the correction(s) will be completed. Your response should be sent to FDAlnternetPharmacyTaskForce-CDER@fda.hhs.gov. Please direct any inquiries concerning this letter to FDA’s Internet Pharmacy Task Force at FDAlnternetPharmacyTaskForceCDER@fda.hhs.gov or (301) 796-3110.

Sincerely,

/s/

Deborah M. Autor, Esq.
Director
Office of Compliance
Center for Drug Evaluation and Research

Cc:
Protected Domain Services – Customer ID: NCR-1083643
125 Rampart Way, Suite 300
Denver, CO 80230
doctorphentermine.com@protecteddomainservices.com
doctorphentermine.com

Steven Rook
Regents Blvd
Union City, California 94587
redisonberg@gmail.com
trusted-tabs.us

Domains by Proxy, Inc., DomainsByProxy.com
15111 N. Hayden Rd., Ste 160, PMB 353
Scottsdale, Arizona 85260
United States
ONLINE-PHARMACY-NO-PRESCRIPTION.COM@domainsbyproxy.com
online-pharmacy-no-prescription.com
prescriptionsintl.com

WhoisGuard
8939 S. Sepulveda Blvd. #110 – 732
Westchester, CA 90045
US
365pharm.com
approved-pharm.com
value-drugstore.com
aprixe.com
buycanadianpharmacy.net

Scott Stiverson
XP Hosting and Design
1938 Eagle Crest Dr
Draper, UT 84020
US
info@xphostinganddesign.com
cheapphentermine.com

NameCheap.com NameCheap.com
8939 S. Sepulveda Blvd. #110 – 732
Westchester, CA 90045
6763d4f87c15430b92099daadd0d9f0a.protect@whoisguard.com
rx-giant.com

ESALES, LLC
One Commerce Center
1201 Orange Street, Suite 600
Wilmington, Delaware 19899
rampage76@cyber-rights.net
4cheaprx.com

Gregg Masters
MorMax, LLC
1644 Corte Verano
Oceanside, CA 92056
greggmasters@gmail.com
preferredpharma.com

Sergey Nikolaev
Chaykovskogo 28 apt 39
Nikolaev
Mykolaiv Oblast
54018
UA
nikolos00@gmail.com
terameds.org

Chris Walsh c/o Dynadot Privacy
PO Box 701
San Mateo, CA 94401
United States
dragon-rx.com
bestrxpharm.net
pharma-direct.com
buy-canadian-pharm .com
easy-pharm.com
Iicensed-medical.com
rxcalm.com
top-hotpills.com
top-uspharm.com
smsrx.net
total-pharma.com

James Riley c/o Dynadot Privacy
PO Box 701
San Mateo, CA 94401
United States
my-pharm.com

PrivacyProtect.org
Domain Admin
contact@privacyprotect.org
first-refill-c1ub.com

Gordon Mcleod c/o Dynadot Privacy
PO Box 701
San Mateo, CA 94401
United States
my-refill-drugstore.com
refill-rx-now.com
rxontv.com

Sergiy Nikolaev c/o Dynadot Privacy
PO Box 701
San Mateo, CA 94401
United States
my-pill.com

Janis Larsen c/o Dynadot Privacy PO Box 701 San Mateo, CA 94401 United States
pharma-discounts.com

FDA WARNING

Money Mules: The Hidden Side of Phishing

Online Fraud Depends on an Offline Component—People Who Launder Money

The dramatic rise in phishing and identity theft attacks includes a well-organized offline component—the not-so-innocent “money mule” recruited by fraudsters to launder stolen money across the globe.

The ads appear innocently on all the major employment listing sites, offering stay-at-home positions titled “shipping manager,” “private financial receiver” or “sales representative.”

These, however, are active attempts at enlisting people—mostly in the United States, the United Kingdom and Australia—to transfer illegal funds from credit card thieves operating out of the former Soviet Union, according to an investigation by VeriSigns iDefense security research outfit.

“This is the other side of phishing that most people never see or hear about. But, its probably the most important part of the attack,” said Ken Dunham, director of the Rapid Response Team at iDefense, in Dulles, Va. “Without the money mule, they really cant do anything with stolen credit card credentials,” Dunham added.

Using hijacked PCs in well-stocked botnets, crime rings have hit pay dirt via adware installations, spam runs and phishing e-mails that attempt to trick users into entering log-in credentials on fake sites.

Once the phish is successful and the malicious attacker has access to credit card and bank log-in details, there is a desperate need for a money mule in the same country as the victim to handle money transfers or to reship items to the fraudster.

The recruitment drive also includes well-designed Web sites that serve as fronts for the companies recruiting the money mules, Dunham said. iDefense found that all such Web sites it investigated were registered in Panama, the home of WebMoney, one of the most popular electronic money services among credit card thieves, also called carders.

eWEEK responded to a Craigslist advertisement for a “regional assistant” and got an immediate response from the hiring manager for Terenfc, an outfit that describes itself as a wholesale product distribution service. Terenfc offered a commission of $50 per received package/operated transfer plus a base salary of $2,000 per month.

eBay and PayPal remain the top phishing targets, a study says. Read more here.

A week later, a follow-up e-mail arrived with two Microsoft Word attachments—a personal information form and an employment agreement. The first form requested complete data on the job seeker, including name, address, phone number, bank account number and PayPal account information.

The employment agreement sets out in plain terms the requirements of the money mule. It reads, in part:

• To accept merchandise orders at his/her residential address;

• To handle the received merchandise in accordance with the reasonable conditions of handling of items;

• To fill in all the necessary postal documents of the postal service company in complete accordance with the instructions;

• To ship the item or merchandise to the address listed in the instructions;

• To scan and send via e-mail or fax all postal documents attached to the shipped correspondence (such as invoices, package slips, custom declarations, receipts or couriers tracking numbers) to the representative of the company within one business day.

The recruitment of money mules has been aggressive in the United Kingdom, prompting the formation of Bank Safe Online, a phishing awareness campaign launched by a consortium of British banks. The initiative, which is managed by the Association for Payment Clearing Services, or APACS, has zeroed in on the money mule scam, issuing stern warnings about the fake jobs and the risks involved with reshipping and laundering money.

Jemma Smith, a spokesperson for Bank Safe Online, in London, said the attempts to enlist mules have moved beyond misspelled spam ads and are now “very slick-looking sites offering what [appear] to be bona fide jobs.”

For advice on how to secure your network and applications, as well as the latest security news, visit Ziff Davis Internets Security IT Hub.

Once recruited, Smith said money mules will receive stolen funds into their accounts. The mules then are asked to take these funds out of their account and forward them overseas (minus a commission payment), typically using a wire transfer service.

“Acting as a mule is an illegal activity. When caught, money mules often have their bank accounts suspended. Weve had a few arrests and some ongoing investigations here in the U.K.,” Smith said.

In some cases, Smith said money mules are encouraged to open multiple accounts with the same bank as the identity theft victim. “If the mule is collusive, they can have multiple accounts in multiple banks, do small transfers just to stay under the radar. This is a big, big part of the problem because, without the mule, the phisher has no way to get the stolen money,” Smith added.

Money Mules explained

  • Fraudsters contact prospective victims with job vacancy ads via spam e-mail, Internet chat rooms or job search Web sites. Jobs usually are advertised as financial management work, and ads suggest that no special knowledge is required.
  • The crime rings persuade the victim to come and work for their fake company. Some fraudsters even ask mules to sign official-looking contracts of employment.
  • Once recruited, money mules receive funds into their accounts. These funds are stolen from other accounts that have been compromised.
  • Mules then are asked to take these funds out of their accounts and forward them overseas (minus a commission payment), typically using a wire transfer service.